Log in
Enquire now
‌

US Patent 11298343 Method for treating thalassemia

Patent 11298343 was granted and assigned to St. Jude Children's Research Hospital on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Current Assignee
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11298343
Date of Patent
April 12, 2022
Patent Application Number
16758986
Date Filed
October 26, 2018
Patent Primary Examiner
‌
Raymond J. Henley, III
CPC Code
‌
A61K 31/7052
‌
A61K 31/495
‌
A61K 31/4164
‌
A61P 7/06

Methods for removing excess free α-globin in erythroid cells and treating a thalassemia using an agent that activates Unc-51 Like autophagy activating Kinase (ULK) are described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11298343 Method for treating thalassemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.